DE69917756D1 - Methoden zur behandlung von neurombedingten schmerzen - Google Patents

Methoden zur behandlung von neurombedingten schmerzen

Info

Publication number
DE69917756D1
DE69917756D1 DE69917756T DE69917756T DE69917756D1 DE 69917756 D1 DE69917756 D1 DE 69917756D1 DE 69917756 T DE69917756 T DE 69917756T DE 69917756 T DE69917756 T DE 69917756T DE 69917756 D1 DE69917756 D1 DE 69917756D1
Authority
DE
Germany
Prior art keywords
neuroma
methods
treating
local anesthetic
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69917756T
Other languages
English (en)
Other versions
DE69917756T2 (de
Inventor
S Galer
J Caldwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caldwell Galer Inc
Original Assignee
Caldwell Galer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caldwell Galer Inc filed Critical Caldwell Galer Inc
Application granted granted Critical
Publication of DE69917756D1 publication Critical patent/DE69917756D1/de
Publication of DE69917756T2 publication Critical patent/DE69917756T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
DE69917756T 1998-03-20 1999-03-15 Methoden zur behandlung von neurombedingten schmerzen Expired - Fee Related DE69917756T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/045,285 US6103771A (en) 1998-03-20 1998-03-20 Method of treating neuroma pain
US45285 1998-03-20
PCT/US1999/005553 WO1999048485A1 (en) 1998-03-20 1999-03-15 Method of treating neuroma pain

Publications (2)

Publication Number Publication Date
DE69917756D1 true DE69917756D1 (de) 2004-07-08
DE69917756T2 DE69917756T2 (de) 2005-06-16

Family

ID=21937019

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917756T Expired - Fee Related DE69917756T2 (de) 1998-03-20 1999-03-15 Methoden zur behandlung von neurombedingten schmerzen

Country Status (10)

Country Link
US (1) US6103771A (de)
EP (1) EP1063978B1 (de)
JP (1) JP2002507563A (de)
AT (1) ATE268173T1 (de)
CA (1) CA2322745C (de)
DE (1) DE69917756T2 (de)
DK (1) DK1063978T3 (de)
ES (1) ES2221373T3 (de)
PT (1) PT1063978E (de)
WO (1) WO1999048485A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
AU2002344968A1 (en) * 2002-05-15 2003-12-02 Johannes Wohlrab Medicinal preparation in a colloid for topical application in the therapy and prophylaxis of states of pain and itching
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US20060079558A1 (en) * 2004-09-27 2006-04-13 Bridge Pharma. Inc. R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
ES2388355T3 (es) 2006-11-03 2012-10-11 Durect Corporation Sistemas de suministro transdémico que comprenden bupivacaína
WO2013052770A1 (en) * 2011-10-05 2013-04-11 Sanders Jennifer L Methods and compositions for treating foot or hand pain

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560553A (en) * 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4963591A (en) * 1985-12-16 1990-10-16 Carter-Wallace Inc. Cosmetic compositions
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
EP0399432B1 (de) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermales therapeutisches Mittel
US5070084A (en) * 1990-02-26 1991-12-03 Campbell James N Treatment of sympathetically maintained pain
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP2849950B2 (ja) * 1990-11-30 1999-01-27 日東電工株式会社 経皮吸収製剤
US5401728A (en) * 1992-04-02 1995-03-28 Simon; John A. Lecithin based topical liniment
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5330452A (en) * 1993-06-01 1994-07-19 Zook Gerald P Topical medicating device
US5543148A (en) * 1994-07-12 1996-08-06 Combe, Incorporated Stick delivery system for topical application of a treatment agent
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5667719A (en) * 1995-06-02 1997-09-16 Hoechst Celanese Corp. High extinction polarizer films comprising liquid crystal polymeric moieties
US5667799A (en) * 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions

Also Published As

Publication number Publication date
CA2322745C (en) 2009-08-04
ES2221373T3 (es) 2004-12-16
DE69917756T2 (de) 2005-06-16
EP1063978A1 (de) 2001-01-03
DK1063978T3 (da) 2004-09-27
CA2322745A1 (en) 1999-09-30
EP1063978A4 (de) 2002-07-03
WO1999048485A1 (en) 1999-09-30
US6103771A (en) 2000-08-15
JP2002507563A (ja) 2002-03-12
ATE268173T1 (de) 2004-06-15
PT1063978E (pt) 2004-10-29
EP1063978B1 (de) 2004-06-02

Similar Documents

Publication Publication Date Title
DE69613840T2 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
BR9508373A (pt) Preparação farmacêutica uso da preparação farmacêutica e processos para preparar a preparação farmacêutica e para aliviar dor
DE59703511D1 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
Leshin et al. Lasers: carbon dioxide laser matricectomy
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
ATE268173T1 (de) Methoden zur behandlung von neurombedingten schmerzen
NO971182D0 (no) Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE60134656D1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
RU2000106839A (ru) Способ лечения фурункулов лица
RU96113759A (ru) Способ лечения гландулярного хейлита
RU97109107A (ru) Способ лечения гнойных ран

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee